As an endogenous agonist at the cannabinoid receptor CB1 and the capsaicin-receptor TRPV1, anandamide may exert both anti-and pronociceptive actions. Therefore, we studied the effects of anandamide and other activators of both receptors on changes in free cytosolic 
Introduction
The arachidonic acid derivative anandamide (N-arachidonoylethanolamine; Devane et al. 1992) , initially identified as an endogenous agonist of the cannabinoid receptor CB1 (Matsuda et al. 1990) , was later also shown to activate the vanilloid receptor TRPV1, a transduction channel for chemical and thermal noxious stimuli (Zygmunt et al. 1999; Smart et al. 2000) . This dual mode of action predicts a complex mixture of anti-and pronociceptive effects of anandamide in the peripheral and in the central nervous system. ] i in response to capsaicin, the "hot" ingredient in chili (Caterina et al. 1997; Caterina and Julius 2001) . TRPV1 is strongly expressed in small to medium size DRG neurons (Caterina et al. 1997; Caterina et al. 1999; Guo et al. 1999; Greffrath et al. 2003; Binzen et al. 2006) that are somata of A delta and C-fiber afferents (Harper and Lawson 1985) . The majority of the small DRG neurons -including the capsaicin sensitive ones -are primary nociceptive neurons that sustain the tranduction of nociceptive stimuli into generator potentials and the subsequent transformation into action potential discharges at their peripheral terminals (Burgess and Perl 1973, Messlinger 1997) . When activated, TRPV1 permits entry of sodium and calcium ions into the neuron. The resulting depolarization induces action potential discharges (Cesare and McNaughton 1996) that can be conducted centripetally. Depolarization also triggers opening of voltage-gated calcium channels (Greffrath et al. 2001) . As a consequence, [Ca 2+ ] i is strongly increased by influx from extracellular space. Intracellular stores express functional TRPV1, too, and therefore contribute to the [Ca 2+ ] i -transients by releasing calcium into the cytosol in response to capsaicin (Eun et al. 2001) or noxious heat (Greffrath et al. 2001 ).
The concentration of intracellular calcium is a key signal in primary nociceptive neurons. At the peripheral terminals it controls desensitization upon repeated stimulation (Tominaga et al. 1998 ), sensitization by strong nociceptive signals (Guenther et al. 1999 ) and electrical excitability via calcium-activated K + channels of the BK, SK and IK types (Gold et al. 1996; Scholz et al. 1998; Mongan et al. 2005) . At the central terminals, transmitter release and thus, synaptic transmission to the central nervous system, is controlled by calcium concentration.
We were therefore interested in studying the effects of anandamide on intracellular calcium concentration in acutely dissociated DRG neurons that served as models of both their peripheral and central terminals.
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The following questions were addressed: Does anandamide increase intracellular calcium concentration in DRG neurons via TRPV1 and are the mechanisms of this increase similar to that by capsaicin and noxious heat? Is there a simultaneous inhibition of nociceptor excitation in the same neurons via co-activation of CB1? How does the functional interaction of TRPV1
and CB1 affect the transduction and transformation process of noxious stimuli in native nociceptive DRG neurons?
Materials and Methods:

Preparation of acutely dissociated DRG neurons
Adult Sprague Dawley Rats (100 -380 g) were deeply anaesthetized with diethylether and decapitated. This method is in accordance with German national law, the principles for animal welfare and is approved by the representative for animal care and use of the University of Mainz. Dorsal root ganglia (DRG) were obtained from the rat spine in chilled F12-Dulbecco´s modified Eagle´s medium at 4°C (Sigma, Taufkirchen, Germany) containing 26 mM NaHCO 3 (Merck, Darmstadt, Germany), 100 IU ml -1 penicilline and 100 µg ml -1 streptomycin (Sigma). The F12 medium was equilibrated with 95 % O 2 / 5 % CO 2 (Carbogengas; Westfalen AG, Muenster, Germany) and adjusted to pH 7.4 with NaOH. Collagenase (CLS II;
Biochrom, Berlin, Germany) was added to the F12 medium for 50 min at 37°C. DRG were washed in F12 and further mechanically dissociated with fire polished glass pipettes. The cell suspension was plated on a microscope cover glass, which was glued under a hole (10 mm diameter) of a 35 mm culture dish (see Greffrath et al. 2001, for details) . A short plastic tube (14 mm diameter) with a small outlet in its wall was mounted over the coverglass to provide a small residual volume (about 120 µl) for rapid exchange of the bath solutions.
Intracellular calcium measurement
Neurons adhered to the cover glass surface after a resting period of 50 to 90 min at 37°C in a humidified 5 % CO 2 -atmosphere. Nutrient F12 medium was replaced by extracellular solution (ES) containing NaCl 137.6 mM, KCl 5.4 mM, MgCl 0.5 mM, CaCl 2 1.8 mM, glucose 5 mM, (all from Merck) and HEPES 10 mM (Sigma). Neurons were loaded with the fluorescent dye FURA-2AM (1 µM; Calbiochem, Bad Soden, Germany) in a dark place at room temperature for 45 min. To remove extracellular dye, neurons were washed with ES. Flourescence was measured using an inverted microscope (IMT-2; Olympus, Hamburg, Germany) and a photon counting device (Photon Technology International PTI, Brunswick, NJ, USA). Some additional calcium-imaging experiments were performed using a rapid imaging system with an IMAGO-CCD camera and TILLvisION software (TILL Photonics GmbH; Graefelfing, Germany). The ratio of the flourescence emission intensities at 510 nm after alternating excitation with light of 340 nm and 380 nm wavelength (340nm/380nm [510nm]) was calculated and digitized at 10 Hertz by a personal computer running OSCAR software (PTI).
This fluorescence ratio is a relative measure of intracellular calcium concentration (Grynkiewicz et al, 1985) . Only small diameter neurons up to 30 µm were further analyzed.
Determination of anandamide sensitivity
Anandamide sensitivity was determined by application of anandamide at the end of each experiment, concentrations between 10 and 100 µM were used. Transients exceeding mean plus threefold standard deviation of the effect seen during application of ES containing vehicle (i.e., change in fluorescence ratio >0.061) were defined as positive responses (cf., Greffrath et al. 2001) . Only neurons responding to depolarization by 50 mM KCl after ineffective application of anandamide were classified as being anandamide insensitive.
Neurons responding to initial application of ES without any reagents were considered to be mechanically activated and therefore excluded from analysis. Since anandamide-induced calcium transients recovered slowly, if at all, only responses to the first anandamide application were analyzed quantitatively.
Heat stimulation and drug application
Heat stimulation was achieved by fast application of one milliliter of preheated extracellular solution to the bath (pH 7.4 at 50°C) resulting in effective peak temperatures of 48. ] i increased spontaneously upon restoration of extracellular calcium -even after long wash-out periods with calcium-free solution (Fig. 2B ). The remaining neurons displaying a successful wash-out responded to a second dose of anandamide ( Fig. 2A) 
Interaction of noxious heat and anandamide
Sixty-five anandamide-sensitive small DRG neurons tested with the supramaximal concentration of 100 µM were also tested with noxious heat stimuli (47°C for 10 s). Figure   6A displays a typical example for a neuron markedly responding to a heat pulse. Those ] i -increases were highly correlated (r = 0.84, n = 65, p < 0.001; Fig. 6B ).
However, responses to noxious heat were constantly larger than those to 100 µM anandamide, as indicated by the slope of the regression line of 1.47 (black line in Fig. 6B ). The same was true for the correlation of the AEA-responses with responses to the respective second (r = 0.88, n = 64, p<0.001; slope 1.39) and third heat pulse in these neurons (r = 0.77, n = 13, p<0.005; slope 1.15).
When stimulated repetitively, heat-responses slightly decreased from stimulus to stimulus with the main decrease seen from the first to the second heat pulse ( 
The endocannabinoid anandamide co-activates CB1 and TRPV1 in native DRG neurons
Although the somata of DRG neurons express both TRPV1 and CB1, the degree of overlap is controversial, ranging from 7 % to 98 % ( The inhibitory interaction between CB1 and TRPV1 may occur in vivo at the terminals of the peripheral axon branches of DRG neurons, i.e. at nociceptive nerve endings in target tissues such as skin or muscle (Walker and Hohmann 2005) . Indeed, CB1-agonists were effective in reducing pain behavior when applied peripherally in different animal models (Richardson et al. 1998; Dogrul et al. 2003) . Similarly, when applied topically onto human skin, the CB1-agonist HU210 exerted analgesic actions (Rukwied et al. 2003) . Antinociceptive effects mediated via CB1 expressed in peripheral neurons are particularly attractive for the clinical situation as they occur outside the blood-brain barrier.
An integrated view of anandamide actions on native DRG neurons
Anandamide has a higher affinity to CB1 than to TRPV1 (Pertwee 2005), and thus may exclusively activate the inhibitory CB1 at lower concentrations without triggering the excitatory TRPV1. Unfortunately, functional consequences of activation of the G-protein coupled CB1-receptor are more difficult to detect than those of the ion channel TRPV1. The fact that those low doses did not display any visible effect may indicate that the downstream cellular processes that may be inhibited by the G-protein cascade are not tonically active.
With respect to systemic antinociceptive actions of CB1 agonists, such a mode of action suggests antihyperalgesic rather than analgesic activity on primary nociceptive afferents.
In cells over-expressing both CB1 and TRPV1, inhibition of TRPV1 by CB1 occurred only, when adenylate cyclase was active (Hermann et al. 2003) . Adenylate cyclase is activated, for example, during inflammation that in turn leads to peripheral sensitization of nociceptive nerve endings and to behavioral signs of hyperalgesia. Accordingly, inflammatory hyperalgesia, edema as well as capsaicin-evoked plasma extravasation were reduced by anandamide in vivo (Richardson et al. 1998; Dogrul et al. 2003) . 
Conclusions
The modulatory ligand anandamide acts on both TRPV1 and CB1 receptors in our model system for the transduction and transformation of noxious stimuli, but its pro-nociceptive effects dominate. Differences between pro-nociceptive actions of anandamide and those of other TRPV1 agonists are partly due to the lipophilic nature of anandamide, partly due to its concomitant actions on CB1 and on calcium channels. Anandamide facilitates the heat responsiveness of TRPV1 in a calcium-independent manner, an effect that is reduced when co-activating CB1. Using more selective CB1-agonists and antagonists, we obtained evidence that CB1 counteracts activation of TRPV1 by chemical ligands but not by heat, whereas thermal sensitization of TRPV1 was reduced by concomitant CB1 receptor activation. These effects of anandamide suggest a primarily modulatory mode of action in the nociceptive system. CB1 receptors appear to inhibit the sensitization process of nociceptive neurons rather than their activation and thus are attractive peripheral targets for the treatment of hyperalgesia in acute and chronic pain states. 
